Prebiopsy multiparametric MRI (mpMRI) paired with targeted biopsy can improve the detection of clinically significant prostate cancer, according to a study published in JAMA Network Open. Identifying high-risk from low-risk prostate cancers can spare men from unnecessary invasive treatments and treatment-associated morbidity, wrote first author Martha M. C. Elwenspoek, PhD, but doing so remains difficult. “There is, therefore, an...Read More

  A new blood test aims for better detection of prostate cancer, but some say it’s not the breakthrough we’ve been hoping for. Researchers continue to try to improve upon the blood test used to screen for prostate cancer— the prostate-specific antigen (PSA) test. A new test claims to help physicians get more accuracy and avoid unnecessary biopsies. The PSA test...Read More